 Home > Active Ingredient News > Antitumor Therapy > First anti-PAUF single anti-PBP1510 treatment for pancreatic cancer, awarded the title of orphan drug by the FDA

First anti-PAUF single anti-PBP1510 treatment for pancreatic cancer, awarded the title of orphan drug by the FDA

 Last Update: 2020-07-14
 Source: Internet
 Author: User

Tags

triazepine drug

major drug companies

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Prestige BioPharma announced that the U.SFoodand Drug Administration(
FDA) has awarded orphan drug drugs (ODD) for its-up factor (PAUF) monoclonal antibody PBP1510 for the treatment of pancreatic cancerPancreatic cancer is a highly invasive malignant tumor with high morbidity and mortality, with a five-year survival rate of only 9% in the United StatesCurrently, the only treatment option is limited to surgical excision combined with complementary chemotherapyHowever, only 10% to 15% of patients are available because most patients are in a late or metastatic stage at the time ofdiagnosis andand are unable to undergo surgerythe expression of pancreatic adenocarcinoma (PAUF) plays an important role in pancreatic cancer progression, there is currently no targeted molecular therapy for PAUFDrLisa SPark, CEO of Prestige BioPharma, said, "The FDA's orphan drug designation is critical to accelerating the development of PBP1510 and providing a better treatment strategy for pancreatic cancer"
FDA awarded THE OD, the drug for the treatment, diagnosis, or prevention affecting less than 200,000 people in the United States Prestige Biopharma has also applied to the European Medicines Agency for the european Union's designated orphan drug designation

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.